Verastem
Develops and commercializes targeted cancer therapies for patients with RAS/MAPK pathway-driven cancers
Highlights
- New on EvolcAdded 2026-11-13
About Verastem
Verastem Oncology develops cancer medicines, including therapies targeting the RAS/MAPK pathway. Its research includes KRAS G12D inhibition, RAF/MEK inhibition and FAK inhibition.
The company serves patients with hard-to-treat cancers and collaborates with partners on therapy development. It has an FDA-approved treatment for KRAS-mutant recurrent low-grade serous ovarian cancer and a pipeline of clinical-stage therapies.
Product: Cancer therapies, including an FDA-approved treatment for KRAS-mutant recurrent low-grade serous ovarian cancer and a pipeline of targeted medicines.
Jobs at Verastem
More biotech & pharma companies
Viatris
Global pharmaceutical company supplying generic, branded and innovative medicines to patients and healthcare markets worldwideVilya
AI-driven drug design company creating novel macrocycle therapeutics for diseases with limited treatment optionsNew on EvolcVir Biotechnology
Develops antibody-based medicines for patients with infectious diseases and cancerNew on EvolcVivodyne
Human-tissue experimentation and biological data platform for biopharma drug discovery and therapeutic developmentNew on EvolcWatchmaker Genomics
Enzymes and reagents for NGS library prep and molecular diagnostics, sold to life science researchers and diagnostics developersRemote-friendlyXenon Pharmaceuticals
Develops neuroscience medicines for people with neurological and psychiatric disordersNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Website resourcedeclared script/iframe or software asset
Forms
- Google reCAPTCHAHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Gravity FormsHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Recruiting
- BambooHRHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.